Effect of nonsurgical periodontal therapy on interleukin-34 levels in periodontal health and disease

Background: Interleukin-34 (IL-34) is a recently identified alternative ligand for colony-stimulating factor-1 receptor plays an important role in osteoclastogenesis. The aim of this study was to evaluate the IL-34 levels in gingival crevicular fluid (GCF) and plasma in subjects with chronic periodo...

Full description

Bibliographic Details
Main Authors: Guruprasad, C. (Author), Pradeep, A. (Author)
Format: Article
Language:English
Published: Medknow Publications 2018
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02920nam a2200493Ia 4500
001 10.4103-ijdr.IJDR_527_17
008 220706s2018 CNT 000 0 und d
020 |a 09709290 (ISSN) 
245 1 0 |a Effect of nonsurgical periodontal therapy on interleukin-34 levels in periodontal health and disease 
260 0 |b Medknow Publications  |c 2018 
856 |z View Fulltext in Publisher  |u https://doi.org/10.4103/ijdr.IJDR_527_17 
520 3 |a Background: Interleukin-34 (IL-34) is a recently identified alternative ligand for colony-stimulating factor-1 receptor plays an important role in osteoclastogenesis. The aim of this study was to evaluate the IL-34 levels in gingival crevicular fluid (GCF) and plasma in subjects with chronic periodontitis and to evaluate the effect of nonsurgical periodontal therapy on the GCF and plasma IL-34 levels. Materials and Methods: Thirty individuals (age range: 30-56 years) were selected and divided into groups based on the gingival index, probing pocket depth, clinical attachment level, and radiologic parameters (bone loss): Group I (15 individuals with healthy periodontium), Group II (15 individuals with chronic generalized periodontitis) while Group II patients after 8 weeks of the treatment (scaling and root planning) constituted Group III. GCF samples and plasma samples were collected to estimate the levels of IL-34 using enzyme-linked immunosorbent assay kit. Results: The mean IL-34 concentration in GCF and plasma was highest for Group II compared to Group I and decreased after nonsurgical periodontal therapy in chronic generalized periodontitis group. The difference between them was statistically significant (P < 0.05). Conclusion: IL-34 can be considered as an 'inflammatory marker' of periodontal disease and can be explored in the future as a potential therapeutic target in the treatment of periodontal disease. © 2018 Indian Journal of Dental Research | Published by Wolters Kluwer - Medknow. 
650 0 4 |a adult 
650 0 4 |a Adult 
650 0 4 |a biological marker 
650 0 4 |a Biomarkers 
650 0 4 |a chemistry 
650 0 4 |a dental scaling 
650 0 4 |a Dental Scaling 
650 0 4 |a enzyme linked immunosorbent assay 
650 0 4 |a Enzyme-Linked Immunosorbent Assay 
650 0 4 |a female 
650 0 4 |a Female 
650 0 4 |a Gingival crevicular fluid 
650 0 4 |a Gingival Crevicular Fluid 
650 0 4 |a gingivitis 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a interleukin derivative 
650 0 4 |a interleukin-34, human 
650 0 4 |a Interleukins 
650 0 4 |a male 
650 0 4 |a Male 
650 0 4 |a metabolism 
650 0 4 |a middle aged 
650 0 4 |a Middle Aged 
650 0 4 |a periodontitis 
650 0 4 |a Periodontitis 
650 0 4 |a plasma 
650 0 4 |a root planing 
650 0 4 |a Root Planing 
700 1 |a Guruprasad, C.  |e author 
700 1 |a Pradeep, A.  |e author 
773 |t Indian Journal of Dental Research